BRAINSTORM CELL THERAPEUTICS INC.

BCLI · OTCM

CIK 1137883fmd_1GDRGPG4R8H4TWYC141RHSKC7TManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Sep 23, 2000 to Jun 30, 2026, 75 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.